Difference between revisions of "PhUSE Archived Projects"
From PHUSE Wiki
Laurenwhite (talk | contribs) m |
Laurenwhite (talk | contribs) m (→Concluded Projects) |
||
(8 intermediate revisions by 2 users not shown) | |||
Line 5: | Line 5: | ||
|- | |- | ||
| '''Project Title''' || '''Working Group''' || '''Final Deliverable''' || '''Concluded''' | | '''Project Title''' || '''Working Group''' || '''Final Deliverable''' || '''Concluded''' | ||
+ | |- | ||
+ | | [https://www.phusewiki.org/wiki/index.php?title=Define-XML_V2.0_Completion_Guidelines_%26_Style_Sheet_Recommendations Stylesheet Recommendations] || Optimizing the Use of Data Standards || [https://www.phuse.eu/phuse-references Recommendations] || March 2019 | ||
+ | |- | ||
+ | | [https://www.phusewiki.org/wiki/index.php?title=Define-XML_V2.0_Completion_Guidelines_%26_Style_Sheet_Recommendations Completion Guidelines] || Optimizing the Use of Data Standards || [https://www.phusewiki.org/docs/WorkingGroups/Deliverables/PhUSE%20Define-XML%202.0%20Completion%20Guidelines%20V1.0.pdf White Paper] || June 2019 | ||
|- | |- | ||
| '''[[Evaluation_Of_Alternative_Transport_Formats|Alternative Transport for the Next Generation]]''' || Emerging Trends & Technologies || [https://www.phuse.eu/white-papers PhUSE White Paper] || 2017 | | '''[[Evaluation_Of_Alternative_Transport_Formats|Alternative Transport for the Next Generation]]''' || Emerging Trends & Technologies || [https://www.phuse.eu/white-papers PhUSE White Paper] || 2017 | ||
|- | |- | ||
| '''[[Application of SEND Data for Analysis]]''' || Nonclinical Topics || [https://www.phuse.eu/white-papers PhUSE White Paper] || 2015 | | '''[[Application of SEND Data for Analysis]]''' || Nonclinical Topics || [https://www.phuse.eu/white-papers PhUSE White Paper] || 2015 | ||
+ | |- | ||
+ | |[[Best_Practices_for_Metadata_Documentation_(define.xml_versus_reviewer’s_guide)|Best Practices for Metadata Documentation: Define XML vs Reviewers Guide]] || Optimizing the use of Data Standards || [https://www.phusewiki.org/docs/Deliverables/Best%20Practices%20for%20Documenting%20%20Dataset%20Metadata%20-%20Define-XML%20versus%20%20Reviewers%20Guide%20-%2005APR2019.pdf White Paper] || 2019 | ||
|- | |- | ||
||Biomarkers ||[[Investigating_Endpoint_Modeling_-_Biomarkers#Deliverables|Poster and white paper]] || [[Investigating Endpoint Modeling - Biomarkers]] || | ||Biomarkers ||[[Investigating_Endpoint_Modeling_-_Biomarkers#Deliverables|Poster and white paper]] || [[Investigating Endpoint Modeling - Biomarkers]] || | ||
Line 16: | Line 22: | ||
||Clinical Endpoint predictivity || [[NICE#Project_Activities_Completed_in_2014|Activities completed]] || [[NICE|NICE: Nonclinical data Interconnectivity for Clinical Endpoint predictivity]] || | ||Clinical Endpoint predictivity || [[NICE#Project_Activities_Completed_in_2014|Activities completed]] || [[NICE|NICE: Nonclinical data Interconnectivity for Clinical Endpoint predictivity]] || | ||
|- | |- | ||
− | |'''[[Clinical_Trials_Data_as_RDF|Clinical Trials Data as RDF]]'''|| Emerging Trends | + | |'''[[Clinical_Trials_Data_as_RDF|Clinical Trials Data as RDF]]'''|| Emerging Trends & Technologies || [https://www.phusewiki.org/docs/Deliverables/Clinical%20Trial%20Data%20as%20RDF%20White%20Paper%20(6).pdf PhUSE White Paper] || 2019 |
|- | |- | ||
| '''[[Data Validation and Quality Assessment]]''' || Optimizing the Use of Data Standards || Validation Rules || 2013 | | '''[[Data Validation and Quality Assessment]]''' || Optimizing the Use of Data Standards || Validation Rules || 2013 | ||
Line 23: | Line 29: | ||
|- | |- | ||
||Emerging Technologies || IG search tool (to add link) || [[Emerging Technologies Collaboration]] || | ||Emerging Technologies || IG search tool (to add link) || [[Emerging Technologies Collaboration]] || | ||
+ | |- | ||
+ | |'''[https://www.phusewiki.org/wiki/index.php?title=Future_Forum_Interoperability_%26_Technology Future Forum Interoperability & Technology]''' || Emerging Trends & Technologies || N/A || 2017 | ||
|- | |- | ||
|Histopathology Visualization || [[Visualization_of_Group_Related_Differences_in_Histopatholgy_Data#Deliverables_For_2015_Project_Year|Deliverables]] || [[Visualization of Group Related Differences in Histopatholgy Data]] || | |Histopathology Visualization || [[Visualization_of_Group_Related_Differences_in_Histopatholgy_Data#Deliverables_For_2015_Project_Year|Deliverables]] || [[Visualization of Group Related Differences in Histopatholgy Data]] || | ||
Line 32: | Line 40: | ||
||Interorganizational SEND || [[Interorganizational_SEND#Accomplished|Accomplishments]] || [[Interorganizational SEND]] || | ||Interorganizational SEND || [[Interorganizational_SEND#Accomplished|Accomplishments]] || [[Interorganizational SEND]] || | ||
|- | |- | ||
− | |[[ | + | |'''[[Introduction_to_Clinical_Development_Design_(CDD)_Framework|Introduction to Clinical Development Design (CDD) Framework]] '''|| Emerging Trends and Technologies||[https://www.phusewiki.org/wiki/images/2/2e/Banach_DIA2018_CDD_Poster.pdf 2018 DIA Poster: The Clinical Development Design (CDD) Framework-Assisting and Improving Decision-Making for Product Development] ||2018 |
|- | |- | ||
− | |[[Introduction_to_Clinical_Development_Design_(CDD)_Framework|Introduction to Clinical Development Design (CDD) Framework]] || Emerging Trends and Technologies||[http://www.appliedclinicaltrialsonline.com/barriers-and-solutions-smart-clinical-program-designs 2017 ACT Paper: Barriers and Solutions to Smart Clinical Program Designs] || 2017 | + | |'''[[Introduction_to_Clinical_Development_Design_(CDD)_Framework|Introduction to Clinical Development Design (CDD) Framework]]''' || Emerging Trends and Technologies||[http://www.appliedclinicaltrialsonline.com/barriers-and-solutions-smart-clinical-program-designs 2017 ACT Paper: Barriers and Solutions to Smart Clinical Program Designs] || 2017 |
|- | |- | ||
− | |[[Introduction_to_Clinical_Development_Design_(CDD)_Framework|Introduction to Clinical Development Design (CDD) Framework]] || Emerging Trends and Technologies||[https://www.phusewiki.org/wiki/images/f/f5/CDD_Introduction_v1.pdf 2016 PhUSE White Paper: Introduction to the Clinical Development Design (CDD) Framework] ||2016 | + | |'''[[Introduction_to_Clinical_Development_Design_(CDD)_Framework|Introduction to Clinical Development Design (CDD) Framework]] '''|| Emerging Trends and Technologies||[https://www.phusewiki.org/wiki/images/f/f5/CDD_Introduction_v1.pdf 2016 PhUSE White Paper: Introduction to the Clinical Development Design (CDD) Framework] ||2016 |
|- | |- | ||
| '''[[Investigating Endpoint Modeling - Biomarkers ADA data and Immunophenotyping]]''' || NonClinical Topics || [https://www.phuse.eu/phuse-references PhUSE Reference] || 2017 | | '''[[Investigating Endpoint Modeling - Biomarkers ADA data and Immunophenotyping]]''' || NonClinical Topics || [https://www.phuse.eu/phuse-references PhUSE Reference] || 2017 | ||
|- | |- | ||
| '''[http://www.phusewiki.org/wiki/index.php?title=Linked_Data_%26_Graph_Database Linked Data & Graph Databases]''' || Emerging Trends & Technologies || Reformed within ET&T || 2017 | | '''[http://www.phusewiki.org/wiki/index.php?title=Linked_Data_%26_Graph_Database Linked Data & Graph Databases]''' || Emerging Trends & Technologies || Reformed within ET&T || 2017 | ||
+ | |- | ||
+ | |'''[[Metadata_Management|Metadata Management]]''' || Emerging Trends & Technologies || [https://www.phusewiki.org/wiki/images/c/cc/ET-project-_Metadata_definitions-V1-2014_07_15.pdf White Paper] || 2014 | ||
|- | |- | ||
|'''[[WG6_Nonclinical_-_Standardization_Roadmap|Nonclinical Standardization Roadmap Team]]''' || Nonclinical Topics || [https://www.phusewiki.org/wiki/index.php?title=%22The_Roadmap_for_Nonclinical_Data_Standards_and_Elements_to_Improve_Data_Access%22 The Roadmap for Nonclinical Data Standards and Elements to Improve Data Access] || 2013 | |'''[[WG6_Nonclinical_-_Standardization_Roadmap|Nonclinical Standardization Roadmap Team]]''' || Nonclinical Topics || [https://www.phusewiki.org/wiki/index.php?title=%22The_Roadmap_for_Nonclinical_Data_Standards_and_Elements_to_Improve_Data_Access%22 The Roadmap for Nonclinical Data Standards and Elements to Improve Data Access] || 2013 | ||
Line 62: | Line 72: | ||
| '''[[Test Submission Forum Group]]''' || Nonclinical Topics || [[Test_Submission_Forum_Polls_and_Results|Poll & Wish List]] || 2015 | | '''[[Test Submission Forum Group]]''' || Nonclinical Topics || [[Test_Submission_Forum_Polls_and_Results|Poll & Wish List]] || 2015 | ||
|} | |} | ||
+ | = Concluded Projects = | ||
+ | |||
+ | '''[[Metadata Management]]'''<br /> | ||
+ | *Metadata Definition Project: [[File:ET-project-template-metadata-definitions.doc]] | ||
+ | *Metadata Management Project: [[File:ET-project-Template - User Guide for E2E meta data management.doc]] | ||
+ | <br> | ||
+ | '''[[Statistical Computing Environments]]''' <br> | ||
+ | <br/> | ||
+ | '''[[Future Forum Interoperability & Technology]]''' <br> | ||
+ | <br> | ||
+ | '''[[Introduction to Clinical Development Design (CDD) Framework]]''' | ||
+ | <br> | ||
+ | '''[[Clinical_Trials_Data_as_RDF|Clinical Trials Data as RDF]]''' | ||
+ | <br> | ||
+ | '''[[Data_Visualisation_as_an_Enabler_for_Nonclinical_Safety_Signal_Detection|Data Visualisation as an Enabler for Nonclinical Safety Signal Detection]]''' | ||
+ | <br> |
Revision as of 04:34, 3 July 2019

Concluded Projects
- Metadata Definition Project: File:ET-project-template-metadata-definitions.doc
- Metadata Management Project: File:ET-project-Template - User Guide for E2E meta data management.doc
Statistical Computing Environments
Future Forum Interoperability & Technology
Introduction to Clinical Development Design (CDD) Framework
Clinical Trials Data as RDF
Data Visualisation as an Enabler for Nonclinical Safety Signal Detection